BBC Among Health Care ETFs
End-of-day Nov 16, 2026 · 39 Health care ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −4.0% | −9.2% | +4.4% | −24.1% | +5.9% | +32.1% | +140.7% | −10.9% | +60.2% |
| Peer average | −1.5% | −3.2% | +4.0% | +1.6% | +19.6% | +25.3% | +73.9% | +24.7% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$25 of every $1,000 in BBC is Kodiak
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | KODKodiak Sciences | Healthcare | 2.47% | $246.63 | 7,349 | $796K |
| 2 | XNCRXencor | Healthcare | 2.40% | $239.93 | 20K | $774K |
| 3 | TRAXFirst Tracks Biotherapeutics | Healthcare | 2.14% | $214.21 | 14K | $691K |
| 4 | REPLReplimune Group | Healthcare | 1.92% | $192.04 | 28K | $619K |
| 5 | ABCLAbCellera Biologics | Healthcare | 1.72% | $172.05 | 48K | $555K |
| 6 | AMLXAmylyx Pharmaceuticals | Healthcare | 1.59% | $158.79 | 17K | $512K |
| 7 | VRDNViridian Therapeutics | Healthcare | 1.45% | $144.64 | 15K | $467K |
| 8 | SGPSpyGlass Pharma | Healthcare | 1.40% | $140.20 | 14K | $452K |
| 9 | MBXMBX Biosciences | Healthcare | 1.19% | $119.12 | 7,049 | $384K |
| 10 | ORKAOruka Therapeutics | Healthcare | 1.17% | $116.56 | 3,581 | $376K |
| 11 | MAZEMAZE Therapeutics | Healthcare | 1.16% | $116.42 | 10K | $376K |
| 12 | LBRXLB Pharmaceuticals | Healthcare | 1.16% | $115.92 | 8,806 | $374K |
| 13 | KYMRKymera Therapeutics | Healthcare | 1.14% | $114.45 | 2,903 | $369K |
| 14 | ANROAlto Neuroscience | Healthcare | 1.11% | $110.66 | 12K | $357K |
| 15 | MANEVeraDermics | Healthcare | 1.09% | $109.26 | 2,605 | $352K |
of the $113B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | KOD | Kodiak Sciences | 2.47% |
| 2 | XNCR | Xencor | 2.40% |
| 3 | TRAX | First Tracks Biotherapeutics | 2.14% |
| 4 | REPL | Replimune Group | 1.92% |
| 5 | ABCL | AbCellera Biologics | 1.72% |
| 6 | AMLX | Amylyx Pharmaceuticals | 1.59% |
| 7 | VRDN | Viridian Therapeutics | 1.45% |
| 8 | SGP | SpyGlass Pharma | 1.40% |
| 9 | MBX | MBX Biosciences | 1.19% |
| 10 | ORKA | Oruka Therapeutics | 1.17% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 29, 2025 | $0.66 |
| Dec 20, 2024 | Dec 27, 2024 | $0.24 |
| Dec 20, 2023 | Dec 29, 2023 | $0.0823 |
| Dec 20, 2017 | Dec 27, 2017 | $0.30 |
| Dec 21, 2015 | Dec 29, 2015 | $0.15 |